Setback for Gilead in GSK HIV antiviral suit

05-05-2020

Setback for Gilead in GSK HIV antiviral suit

nitpicker / shutterstock.com

An Australian federal judge has thrown out a challenge by Gilead Sciences to the wording of infringement claims made by a GlaxoSmithKline (GSK) subsidiary.


Gilead, GlaxoSmithKline, GSK, ViiV, Biktarvy, HIV, antiviral, bictegravir, Australia, Jonathan Beach, Federal Court of Australia

LSIPR